Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics PS Ratio
PS Ratio Chart
Historical PS Ratio Data
| Date | Value |
|---|---|
| January 23, 2024 | 91.82 |
| January 22, 2024 | 91.82 |
| January 19, 2024 | 91.97 |
| January 18, 2024 | 92.00 |
| January 17, 2024 | 92.08 |
| January 16, 2024 | 92.25 |
| January 12, 2024 | 92.72 |
| January 11, 2024 | 92.11 |
| January 10, 2024 | 92.13 |
| January 09, 2024 | 92.35 |
| January 08, 2024 | 92.42 |
| January 05, 2024 | 92.44 |
| January 04, 2024 | 92.16 |
| January 03, 2024 | 92.13 |
| January 02, 2024 | 92.45 |
| December 29, 2023 | 91.89 |
| December 28, 2023 | 92.14 |
| December 27, 2023 | 92.13 |
| December 26, 2023 | 92.28 |
| December 22, 2023 | 92.19 |
| December 21, 2023 | 92.25 |
| December 20, 2023 | 92.22 |
| December 19, 2023 | 91.94 |
| December 18, 2023 | 90.41 |
| December 15, 2023 | 90.39 |
| Date | Value |
|---|---|
| December 14, 2023 | 89.73 |
| December 13, 2023 | 89.73 |
| December 12, 2023 | 88.84 |
| December 11, 2023 | 88.48 |
| December 08, 2023 | 88.36 |
| December 07, 2023 | 88.67 |
| December 06, 2023 | 88.61 |
| December 05, 2023 | 88.72 |
| December 04, 2023 | 89.06 |
| December 01, 2023 | 89.28 |
| November 30, 2023 | 88.76 |
| November 29, 2023 | 89.09 |
| November 28, 2023 | 88.91 |
| November 27, 2023 | 88.64 |
| November 24, 2023 | 88.84 |
| November 22, 2023 | 88.96 |
| November 21, 2023 | 88.33 |
| November 20, 2023 | 88.37 |
| November 17, 2023 | 88.45 |
| November 16, 2023 | 88.19 |
| November 15, 2023 | 87.92 |
| November 14, 2023 | 88.33 |
| November 13, 2023 | 88.00 |
| November 10, 2023 | 88.05 |
| November 09, 2023 | 87.23 |
Price to Sales Ratio Definition
The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.
PS Ratio Range, Past 5 Years
41.16
Minimum
Jul 18 2022
2013.26
Maximum
Jun 25 2020
432.61
Average
176.80
Median
Mar 24 2023
PS Ratio Benchmarks
| Bristol-Myers Squibb Co | 2.503 |
| Karuna Therapeutics Inc (DELISTED) | 1079.41 |
| Puma Biotechnology Inc | 0.6549 |
| NovaBay Pharmaceuticals Inc | 0.0350 |
| Palatin Technologies Inc | -- |
PS Ratio Related Metrics
| Price | 58.70 |